CLASS II Device recall · Reported 28 Aug 2019 · FDA Enforcement Report

BD Vacutainer LH (Lithium Heparin) 68 I.U recalled by Becton Dickinson &

Becton Dickinson & is recalling BD Vacutainer LH (Lithium Heparin) 68 I.U, distributed nationwide in the US. The recall was initiated on 12 Jun 2019 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI: (01)30382903659037
Quantity recalled1,436,228,004 total

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2309-2019
FDA event ID
82963
Recalling firm
Becton Dickinson &, Franklin Lakes, NJ
Classification
Class II
Status
Terminated
Recall initiated
12 Jun 2019
FDA classified
21 Aug 2019
Reported
28 Aug 2019
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

12 Jun 2019Recall initiated by company
21 Aug 2019Classified by FDA+70 days
28 Aug 2019Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

False elevation of carboxyhemoglobin (COHb) results have been reported when using venous blood gas samples collected with tubes analyzed with the IL GEM 4000 instrument.

Product as listed by the FDA

BD Vacutainer LH (Lithium Heparin) 68 I.U. Plus Blood Collection Tubes, Catalog Number 368884

Where it was distributed

Worldwide Distribution, including US Nationwide

Nationwide

Questions about this recall

Is BD Vacutainer LH (Lithium Heparin) 68 I.U recalled?

Yes. Becton Dickinson & recalled BD Vacutainer LH (Lithium Heparin) 68 I.U on 12 Jun 2019. The recall is Class II and its status is Terminated. Recall number Z-2309-2019.

Why was it recalled?

False elevation of carboxyhemoglobin (COHb) results have been reported when using venous blood gas samples collected with tubes analyzed with the IL GEM 4000 instrument.

Which lots are affected?

UDI: (01)30382903659037

Where was it sold?

Worldwide Distribution, including US Nationwide

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Becton Dickinson &

All 361

Other Syringes & Needles recalls

All 1,060